KL and myocardial ischemia: Recombinant Klotho treatment prevented CaMKII‐dependent pathway activation and RyR2 hyperphosphorylation, thereby ameliorating the intracardiomyocyte Ca2+ mishandling and diastolic SR Ca2+ leak observed in IHD.